Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00061932
Status:
COMPLETED
Last Update Posted:
2021-02-02
First Post:
2003-06-05
Brief Title:
Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Gastric Cancer |
| Adenocarcinoma of the Gastroesophageal Junction |
| Diffuse Adenocarcinoma of the Stomach |
| Intestinal Adenocarcinoma of the Stomach |
| Mixed Adenocarcinoma of the Stomach |
| Recurrent Gastric Cancer |
| Stage IIIB Gastric Cancer |
| Stage IIIC Gastric Cancer |
Keywords: